CVE-2017-14111
The workstation logging function in Philips IntelliSpace Cardiovascular (ISCV) 2.3.0 and earlier and Xcelera R4.1L1 and earlier records domain authentication credentials, which if accessed allows an attacker to use credentials to access the application,…
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (2.17%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
The workstation logging function in Philips IntelliSpace Cardiovascular (ISCV) 2.3.0 and earlier and Xcelera R4.1L1 and earlier records domain authentication credentials, which if accessed allows an attacker to use credentials to access the application, or other user entitlements.
- CVSS 3.0
- 7.2 HIGHCVSS:3.0/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 2.17% probability · 82th percentile
- Public exploits
- None in Exploit-DB
- CISA KEV
- Not listed
- Weakness
- CWE-522
- Affected
- philips/intellispace cardiovascular · philips/xcelera
- Source
- cve@mitre.org
EPSS 2.2% since 27 October 2026; no change recorded yet. Points are recorded when the score first appears and whenever it moves by a percentage point or more.
References
- http://www.securityfocus.com/bid/101850Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-17-318-01Issue Tracking, Third Party Advisory, US Government Resource
- https://www.usa.philips.com/healthcare/about/customer-support/product-securityIssue Tracking, Mitigation, Vendor Advisory
- http://www.securityfocus.com/bid/101850Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-17-318-01Issue Tracking, Third Party Advisory, US Government Resource
- https://www.usa.philips.com/healthcare/about/customer-support/product-securityIssue Tracking, Mitigation, Vendor Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.